Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Huperzine A polymorphism body, preparation method thereof, pharmaceutical composition comprising polymorphism body and application thereof

A technology for huperzine A and crystal form, which is applied in the field of preparation of huperzine A polymorph and its synthesis process research field, and can solve problems such as the raw material crystal form of huperzine A is not involved

Active Publication Date: 2014-09-03
SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Currently on the market, huperzine A is mainly administered in the form of oral tablets, capsules, and injections, but none of the formula patents involves the crystal form of the huperzine A raw material used

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Huperzine A polymorphism body, preparation method thereof, pharmaceutical composition comprising polymorphism body and application thereof
  • Huperzine A polymorphism body, preparation method thereof, pharmaceutical composition comprising polymorphism body and application thereof
  • Huperzine A polymorphism body, preparation method thereof, pharmaceutical composition comprising polymorphism body and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0056] Example 1: Preparation of huperzine A crystal form I.

[0057] Mix 50 mg of huperzine A raw material (amorphous) with 1 ml of acetone, heat to 50° C. and keep stirring at 50° C. for 3 days, and filter to obtain a white solid. After evaporating the solvent at room temperature, the white solid was dried under reduced pressure with an oil pump for 12 hours to obtain a crystalline powder, which was determined by X-ray powder diffraction, showing that the obtained crystal form was Form I. The specific peak positions are shown in Table 1 below.

[0058] Table 1: X-ray powder diffraction data of Huperzine A crystal form I in Example 1 of the present invention

[0059]

[0060] Other tests were carried out on the obtained sample, and the obtained DSC thermal spectrum, infrared spectrum and Raman spectrum were as follows: Figure 1b , 1c , 1d shown.

Embodiment 2

[0061] Example 2: Preparation of huperzine A crystal form II.

[0062] Put 25 mg of huperzine A crystal form I in an oven at 125 degrees Celsius and heat for 2 hours to obtain a crystalline powder, which was determined by X-ray powder diffraction to show that the obtained crystal form was crystal form II. The specific peak positions are shown in Table 2 below.

[0063] Table 2: X-ray powder diffraction data of Huperzine A crystal form II in Example 2 of the present invention

[0064]

[0065]

[0066] Other tests were carried out on the obtained sample, and the obtained DSC thermal spectrum, infrared spectrum and Raman spectrum were as follows: Figure 2b , 2c , as shown in 2d.

Embodiment 3

[0067] Example 3: Preparation of huperzine A crystal form III.

[0068] Mix 50 mg of huperzine A crystalline form I with 1 ml of acetonitrile, heat to 50° C. and keep stirring at 50° C. for 2 days, and filter to obtain a white solid. After evaporating the solvent at room temperature, the white solid was placed in a vacuum drying oven at 100°C, and dried for 24 hours under vacuum with an oil pump to obtain a crystalline powder, which was determined by X-ray powder diffraction, showing that the obtained crystal form was crystal Type III. The specific peak positions are shown in Table 3 below.

[0069] Table 3: X-ray powder diffraction data of Huperzine A crystal form III in Example 3 of the present invention

[0070]

[0071] Other tests were carried out on the obtained sample, and the obtained DSC thermal spectrum, infrared spectrum and Raman spectrum were as follows: Figure 3b , 3c , 3d shown.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a huperzine A polymorphism body, a preparation method thereof, a pharmaceutical composition comprising the polymorphism body and an application thereof. Partial of the huperzine A polymorphism body has better solubility than that of a commercially available medicinal crystal form and is more beneficial to absorption of medicine. Partial of the huperzine A polymorphism body has much lower hygroscopicity than that of the commercially available medicinal crystal form and is more beneficial to preparation and storage of medicine preparations.

Description

technical field [0001] The present invention is a divisional application of the patent application for invention with the application number 2012100784749 submitted by the applicant Shanghai Institute of Materia Medica, Chinese Academy of Sciences on March 22, 2012. [0002] The invention belongs to the field of medicinal chemistry polymorph research, and specifically relates to the preparation of huperzine A polymorph by different crystallization methods and the research on its synthesis process. Background technique [0003] Polymorphism refers to the phenomenon that solid substances form solid states with different physical and chemical properties in two or more different spatial arrangements. In the field of pharmaceutical research, polymorphism also includes multi-component crystal forms such as organic solvates and hydrates. Drug polymorphism widely exists in the drug development process and is an inherent characteristic of small organic molecules. Theoretically, sma...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D221/22A61K31/4748A61P25/28A61P25/18
CPCC07D221/22A61P25/18A61P25/28
Inventor 梅雪锋章海燕张奇陆骊烨戴文娟
Owner SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com